Other Stories

Full Video

CDC panel backs full licensing of Pfizer-BioNTech COVID-19 vaccine Updated: 2021-08-31 10:03:01 KST

On Monday, The Advisory Committee on Immunization Practices, a major advisory panel for the U.S. Center for Disease Control and Prevention unanimously endorsed the full approval of Pfizer's COVID-19 vaccine for Americans aged 16 and older.
The backing by the panel comes a week after the U.S. FDA granted the vaccine full approval.
While the endorsement is not binding for the agency, its director, Rochelle Walensky is expected to accept the panel's endorsement shortly.
The agency hopes that the step will convince more people to get inoculated, as the vaccination campaign in the U.S. has slowed due to safety concerns among some of the population.
Reporter : tkim@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.